It has been shown that NGAL actively promotes breast cancer metastasis by inducing VEGF production, EMT, angiogenesis, and cell invasion and migration through multiple signaling pathways, including PI3K/AKT/NF-Κb [87,89,90,91,92,93,94,95]. Here, LCN2 is linked to breast carcinoma.